Purpose The aim of this study was to compare fluorodeoxyglucose positron emission
tomography/computed tomography (FDG PET/CT) and contrast-enhanced computed …

This study aimed to compare contrast-enhanced CT (CE-CT) and 18F-FDG PET/CT for
response monitoring in metastatic breast cancer using the standardized response …

Breast cancer prognosis is steadily improving due to early detection of primary cancer in
screening programs and revolutionizing treatment development. In the metastatic setting …

This study aimed to compare CE-CT and 2-[18F] FDG-PET/CT for response monitoring
metastatic breast cancer (MBC). The primary objective was to predict progression-free and …

Background: We aimed to examine the feasibility and potential benefit of applying PET
Response Criteria in Solid Tumors (PERCIST) for response monitoring in metastatic breast …

Purpose This study examines the use of [18F] fluorodeoxyglucose positron emission
tomography (FDG-PET) for the evaluation of the therapeutic response for patients treated …

The PET Response Criteria in Solid Tumors (PERCIST) are not specific regarding the
number of lesions that should be analyzed per patient. This study evaluated how the number …

Background We compared overall survival for metastatic breast cancer (MBC) patients
monitored with CE-CT, FDG-PET/CT or a combination of them in an observational setting …

Chemotherapy is currently the treatment of choice for patients with high-risk metastatic
breast cancer. Clinical response is determined after several cycles of chemotherapy by …

We investigated the role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography
(PET) in the early evaluation of response to chemotherapy in metastatic breast cancer …